Country: United States
Language: English
Source: NLM (National Library of Medicine)
Butalbital (UNII: KHS0AZ4JVK) (Butalbital - UNII:KHS0AZ4JVK), Acetaminophen (UNII: 362O9ITL9D) (Acetaminophen - UNII:362O9ITL9D), Caffeine (UNII: 3G6A5W338E) (Caffeine - UNII:3G6A5W338E)
Strides Pharma Inc.
ORAL
PRESCRIPTION DRUG
Butalbital, acetaminophen and caffeine tablets, USP are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, acetaminophen, and caffeine tablets, USP in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable. Butalbital, acetaminophen and caffeine tablets, USP are contraindicated under the following conditions: - Hypersensitivity or intolerance to any component of this product. - Patients with porphyria. Butalbital Barbiturates may be habit-forming: Tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. The average daily dose for the barbiturate addict is usually about 1500 mg. As tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does n
Containing 50 mg butalbital, 325 mg acetaminophen, and 40 mg caffeine. Available as white to off-white tablets with a "P580" debossed on one side. NDC 42543-094-01: Bottles of 100 supplied with child-resistant closures. NDC 42543-094-05: Bottles of 500. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight container. Keep out of reach of children. Rx only For all medical inquiries contact: Vensun Pharmaceuticals, Inc. Yardley, PA 19067 1-800-385-1540 Manufactured for: Vensun Pharmaceuticals, Inc Yardley, PA 19067 Manufactured by: Pharmaceutics International, Inc Hunt Valley, MD 21031 Rev. 00, May 2017
Abbreviated New Drug Application
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE- BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLET STRIDES PHARMA INC. ---------- BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP RX ONLY HEPATOTOXICITY ACETAMINOPHEN HAS BEEN ASSOCIATED WITH CASES OF ACUTE LIVER FAILURE, AT TIMES RESULTING IN LIVER TRANSPLANT AND DEATH. MOST OF THE CASES OF LIVER INJURY ARE ASSOCIATED WITH THE USE OF ACETAMINOPHEN AT DOSES THAT EXCEED 4000 MILLIGRAMS PER DAY, AND OFTEN INVOLVE MORE THAN ONE ACETAMINOPHEN-CONTAINING PRODUCT. DESCRIPTION Butalbital, acetaminophen and caffeine tablets, USP are supplied in tablet form for oral administration. Each tablet contains the following active ingredients: butalbital, USP . . . . . . . . . . 50 mg acetaminophen, USP . . . . 325 mg caffeine, USP …………… 40 mg Butalbital (5-allyl-5-isobutylbarbituric acid) is a short-to intermediate-acting barbiturate. It has the following structural formula: C H N O Mol. wt. 224.26 Acetaminophen (4′-hydroxyacetanilide) is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula: C H NO Mol. wt. 151.16 Caffeine (1, 3, 7-trimethylxanthine) is a central nervous system stimulant. It has the following structural formula: 11 16 2 3 8 9 2 C H N O Mol. wt. 194.19 _Inactive Ingredients:_ colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, povidone, pregelatinized starch, crospovidone and stearic acid. CLINICAL PHARMACOLOGY Butalbital, acetaminophen and caffeine tablets, USP are intended as a treatment for tension headache. It consists of a fixed combination of butalbital, acetaminophen, and caffeine. The role each component plays in the relief of the complex of symptoms known as tension headache is incompletely understood. PHARMACOKINETICS The behavior of the individual components is described below. _BUTALBITAL_ Butalbital is well absorbed from the gastrointestinal tract and is expected to distribute to most tissues in the body. Barbiturates in general may appear in breast milk and readily cross the placen Read the complete document